Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
349,461
-
Shares change
-
+296,771
-
Total reported value, excl. options
-
$303,731
-
Value change
-
+$250,853
-
Number of buys
-
11
-
Number of sells
-
-1
-
Price
-
$0.87
Significant Holders of IMPACT BIOMEDICAL INC. - COMMON STOCK (IBO) as of Q1 2025
16 filings reported holding IBO - IMPACT BIOMEDICAL INC. - COMMON STOCK as of Q1 2025.
IMPACT BIOMEDICAL INC. - COMMON STOCK (IBO) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 349,461 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (126,446 shares), HRT FINANCIAL LP (68,158 shares), CITADEL ADVISORS LLC (60,315 shares), BlackRock, Inc. (30,675 shares), GEODE CAPITAL MANAGEMENT, LLC (23,200 shares), UBS Group AG (16,167 shares), STATE STREET CORP (11,797 shares), MORGAN STANLEY (7,800 shares), Tower Research Capital LLC (TRC) (3,766 shares), and WELLS FARGO & COMPANY/MN (1,029 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.